Standout Papers

Anti-HER2 immunoliposomes: enhanced efficacy attributable to targeted delivery. 2002 2026 2010 2018 507
  1. Anti-HER2 immunoliposomes: enhanced efficacy attributable to targeted delivery. (2002)
    John W. Park, Keelung Hong et al. PubMed

Immediate Impact

6 by Nobel laureates 18 from Science/Nature 123 standout
Sub-graph 1 of 16

Citing Papers

Transferrin receptor targeting chimeras for membrane protein degradation
2024 StandoutNature
Force-controlled release of small molecules with a rotaxane actuator
2024 StandoutNature
2 intermediate papers

Works of Gail Colbern being referenced

Pegylated liposomal doxorubicin: Proof of principle using preclinical animal models and pharmacokinetic studies
2004
Anti-HER2 immunoliposomes: enhanced efficacy attributable to targeted delivery.
2002 Standout

Author Peers

Author Last Decade Papers Cites
Gail Colbern 692 307 780 392 20 1.4k
Elaine Westrick 923 607 528 451 28 2.1k
Nikki Parker 691 452 436 396 16 1.6k
Verna Frasca 843 265 360 233 16 1.6k
Elena Geretti 743 466 488 395 30 1.5k
Alberto Gabizon 742 335 827 352 23 1.6k
Jennifer A. MacDiarmid 1290 239 288 417 39 2.2k
Nely Wigler 413 857 628 486 17 1.8k
Yingjuan Lu 865 302 617 504 34 1.7k
J.S.W. Stewart 647 569 860 528 35 2.1k
Stefania Biffi 497 97 267 307 55 1.3k

All Works

Loading papers...

Rankless by CCL
2026